The cyclins: a family of widely expressed tumor antigens?

Identification of a cyclin B1-derived CTL epitope eliciting spontaneous responses in both cancer patients and healthy donors

(2010) Rikke Sick Andersen et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Cell Cycle as a Target of Antineoplastic Drugs

(2010) Maria De Falco et al.   CURRENT PHARMACEUTICAL DESIGN

WT1 peptide vaccine, one of the most promising cancer vaccines: its present status and the future prospects

(2010) Yoshihiro Oka et al.   Immunotherapy

CD8 T-cell Responses against Cyclin B1 in Breast Cancer Patients with Tumors Overexpressing p53

(2009) R. B. Sorensen et al.   CLINICAL CANCER RESEARCH

The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research

(2009) M. A. Cheever et al.   CLINICAL CANCER RESEARCH

Adoptive cell therapy for the treatment of patients with metastatic melanoma

(2009) Steven A Rosenberg et al.   CURRENT OPINION IN IMMUNOLOGY

The shared tumor associated antigen cyclin-A2 is recognized by high-avidity T-cells

(2009) Eisei Kondo et al.   INTERNATIONAL JOURNAL OF CANCER

Multiple pathways in the FGF signaling network are frequently deregulated by gene amplification in oral dysplasias

(2009) Ivy F.L. Tsui et al.   INTERNATIONAL JOURNAL OF CANCER

Using CD40-activated B Cells to Efficiently Identify Epitopes of Tumor Antigens

(2009) Eisei Kondo et al.   JOURNAL OF IMMUNOTHERAPY

Decreased Incidence of Hepatocellular Carcinoma in Hepatitis B Vaccinees: A 20-Year Follow-up Study

(2009) Mei-Hwei Chang et al.   JNCI-Journal of the National Cancer Institute

Cyclin D1 as a universally expressed mantle cell lymphoma-associated tumor antigen for immunotherapy

(2009) M Wang et al.   LEUKEMIA

Modulation of p53, c-fos, RARE, cyclin A, and cyclin D1 expression in human leukemia (HL-60) cells exposed to arsenic trioxide

(2009) Clement G. Yedjou et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

HPV Vaccination for the Prevention of Cervical Intraepithelial Neoplasia

(2009) Jessica A. Kahn   NEW ENGLAND JOURNAL OF MEDICINE

Identification of a Human Cyclin D1-Derived Peptide that Induces Human Cytotoxic CD4 T Cells

(2009) Tao Dao et al.   PLoS One

Healthy individuals have T-cell and antibody responses to the tumor antigen cyclin B1 that when elicited in mice protect from cancer

(2009) L. A. Vella et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Cyclin D1-Specific Cytotoxic T Lymphocytes Are Present in the Repertoire of Cancer Patients: Implications for Cancer Immunotherapy

(2008) E. Kondo et al.   CLINICAL CANCER RESEARCH